Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01887964 · ClinicalTrials.gov registry record · NA
Effect of Resistant Starch (Type-4) on Metabolic Syndrome
A NA study, sponsored by South Dakota State University.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT01887964: Completed NA study, sponsored by South Dakota State University.
NCT01887964 is a NA study that has completed, run by South Dakota State University. The registered enrollment target is 86 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01887964, a NA study, has completed, sponsored by South Dakota State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
Metabolic syndrome is a condition characterized by excess body weight, large waist circumference, high cholesterol and glucose in the blood, and hypertension. People with metabolic syndrome are at increased risk for heart diseases. Research shows benefits of regular fiber intake in metabolic syndrome. However, due to altered taste and texture of the high fiber foods, long term intake of fiber is a challenge for metabolic syndrome patients. This study is designed to find if blinded-substitution of regular wheat flour in domestic kitchen with wheat flour enriched by an adaptable type of fiber (resistant starch-4), minimizes metabolic syndrome symptoms. this special type of fiber is also obtained from wheat.
Interventions
- OTHER RS4 enriched flour
- OTHER Control flour
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-10 |
| Phase | NA |
What the finished NCT01887964 record still lists
NCT01887964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which RS4 enriched flour is the first listed.
NCT01887964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01887964 about?
NCT01887964 is a clinical study titled "Effect of Resistant Starch (Type-4) on Metabolic Syndrome". Metabolic syndrome is a condition characterized by excess body weight, large waist circumference, high cholesterol and glucose in the blood, and hypertension. People with metabolic syndrome are at increased risk for heart diseases. Research shows benefits of regular fiber intake in metabolic syndrom...
What is the current status of trial NCT01887964?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2012-03. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01887964?
The interventions under investigation include: RS4 enriched flour (OTHER), Control flour (OTHER).
Who is sponsoring clinical trial NCT01887964?
This trial is sponsored by South Dakota State University, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01887964's enrollment target sits among peer trials
86 976th of 2000 higher than 1,021 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia